PD-L1NEUT, Foxp3Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma

by Lin Zhou PhD, Jing Wang MD, Shao-cheng Lyu PhD, Li-chao Pan PhD, Xian-jie Shi PhD, Guo-sheng Du PhD, Qiang He PhD
Published 2021-09-01

Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC

by Yue Ren MSc, Shan-Bing Wang MSc, Lin Zhou PhD, Si-Qiao Liu MSc, Lei-Ya Du MSc, Ting Li MSc, Mao-Qiong Jiang BSc, Kai-Jian Lei MSc, Bang-Xian Tan MSc, Yu-Ming Jia BSc
Published 2021-05-01

Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

by Yan-Peng Zhang MD, Zhi-Wei Bao PhD, Jing-Bang Wu PhD, Yun-Hao Chen PhD, Jun-Ru Chen PhD, Hai-Yang Xie PhD, Lin Zhou PhD, Jian Wu PhD, Shu-Sen Zheng PhD
Published 2020-07-01